期刊文献+

MGMT及P53在脑胶质瘤组织中的表达及其生物学意义 被引量:8

Expression of DNA Repair Enzyme MGMT in Human Brain Gliomas and Its Biological Implication
下载PDF
导出
摘要 目的探讨MGMT及P53蛋白在人脑胶质瘤中的表达及其与肿瘤发生和恶性度的关系.方法对39例人脑胶质瘤标本用免疫组化法检测MGMT和P53蛋白的表达,观察两者的相互关系及其和肿瘤恶性度间的关系.结果不同恶性程度胶质瘤间MGMT的阳性表达率无明显区别(p=0.496745),但表达强度却明显不同(p=0.018781), 两者呈明显的负相关(r=-0.629,p<0.05).P53蛋白的阳性表达率(p=0.027648)和表达强度(p=3.5×10-118)在不同恶性程度肿瘤间都有明显差异,与肿瘤的恶性程度呈正相关(r=0.575,p<0.05).MGMT的阳性表达强度和P53蛋白的阳性表达强度呈明显的负相关(r=-0.750,p<0.05).结论MGMT表达减弱和P53表达增强与脑胶质瘤的发生及其恶性程度有一定关系. Objective To explore the MGMT expression in human gliomas and its implication to tumorigenesis and the degree of gliomas' malignancy. Methods After MGMT and P53 protein expression in 39 human brain gliomas were determined by inunanohistochemical technique, we evaluate the relation between MGMT and P53 expression and the one between the degree of gliomas' malignancy and MGMT and P53 expression. Results The differences of MGMT expression intensity were statistically significant among dif-ferent malignant degrees in gliomas (p = 0. 018781 ), showing an inversive correalation with the malignant degrees of gliomas (r = -0.629, p 〈 0.05 ),although the expression positive rate had no difference. Both the positive rate (p = 0.027648 ) and the intensity (p = 3.5 × 10^-118) of P53 expression were significantly different, and had a positive correlation with the malignant degrees (r = 0.575 ,p 〈 0.05). The MGMT expression intensity was inversively correlative to the P53 protein expression (r = -0.750,p 〈 0.05). Conclusions The weak MGMT expression and the strong P53 expression could be related to the tumorigenesis and the degrees of malignancy of human brain gliomas.
出处 《现代临床医学生物工程学杂志》 2005年第3期187-189,201,共4页 Journal of Modern Clinical Medical Bioengineering
关键词 神经胶质瘤 MGMT P53 生物学 Gliomas MGMT P53
  • 相关文献

参考文献14

  • 1张霞,周宜开.MGMT研究进展[J].国外医学(分子生物学分册),2002,24(1):35-37. 被引量:35
  • 2张玉林.中枢神经系统肿瘤的分类和分级探讨——4373例病理分析[J].中华病理学杂志,2002,31(5):420-423. 被引量:15
  • 3Andratschke N, Grosu AL, Molls M, et al. Perspectives in the treatment of malignant gliomas in adults[J]. Anticancer Res,2001,21(5):3541.
  • 4Komine C, Watanabe T, Katayama Y, et al. Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas[J]. Brain Pathol,2003,13(2):176.
  • 5方俊杰,赵洪洋.脑胶质瘤分子遗传学研究进展[J].国外医学(神经病学.神经外科学分册),2005,32(1):45-48. 被引量:13
  • 6Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system[J].J Neuropathol Exp Neurol,2002,61(3):215.
  • 7Yuan Q, Matsumoto K, Nakabeppu Y, et al. A comparative immunohistochemistry of O6-methylguanine-DNA methyltransferase and p53 in diffusely infiltrating astrocytomas[J].Neuropathology,2003,23(3):203.
  • 8Komine C, Watanabe T, Katayama Y, et al. Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients withlow-grade diffuse astrocytomas[J].Brain Pathol,2003,13(2):176.
  • 9Heesters MA, Koudstaal J, Go KG, et al. Proliferation and apoptosis in long-term surviving low grade gliomas in relation to radiotherapy[J].J Neurooncol,2002,58(2):157.
  • 10Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents[J]. N Engl J Med,2000,343(23):1350.

二级参考文献36

  • 1史玉泉.实用神经病学(第2版)[M].上海:上海科学技术出版社,1994.736.
  • 2范郎娣.王德延肿瘤的病理诊断学(第2版)下册[M].天津:天津科学技术出版社,1999.1613-1701.
  • 3张玉林.对神经系统肿瘤的国际分类的新观点[J].中国临床神经科学,2001,9:105-108.
  • 4Balana C, Ramirez JL, Taron M, et al. O6 methylguanine DNA methyltransferase Methylation in Serum and Tumor DNA Predicts Response to 1,3 Bis(2 Chloroethyl) 1 Nitrosourea but not to Temozolamide Plus Cisplatin in Glioblastoma Multiforme [J]. Clin Cancer Res, 2003, 9(4): 1461- 1468.
  • 5Andratachke N, Grosu AL, Molls M, et al. Perspectives in the treament of malignant gliomas in adults [J]. Anticancer Res, 2001, 21(5):3541- 3550.
  • 6Silber JR, Bobola MS, Ghatan S, et al. O6 methylguanine DNA methyltransferase activity in adult gliomas: relation to patient and tumor characteristics [J]. Cancer Res, 1998, 58(5): 1068- 1073.
  • 7Silber JR, Blank A, Bobola MS, et al. O6 methylguanine DNA methltransferase deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent based chemotherapy [J]. Clin Cancer Res, 1999, 5(4): 807- 814.
  • 8Nutt CL, Loktionova NA, Pegg AE, et al. O(6) methylguanine DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes [J]. Carcinogenesis, 1999, 20(12): 2361- 2365.
  • 9Bobola MS, Berger MS, Ellenbogen RG, et al. O6 Methylguanine DNA methyltransferase in pediatric primary brain tumors: relation to patients and tumor characteristics [J]. Clin Cancer Res,2001,7(3):613- 619.
  • 10Esteller M, Garcia Foncillas J, Andion E, et al. Inactivation of the DNA Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents [J]. N Engl J Med, 2000, 343(23):1350- 1354.

共引文献87

同被引文献102

  • 1孙彦辉,张亚卓,王忠诚,孙梅珍,赵东海.MGMT在脑胶质瘤组织中的表达及其与患者生存期的关系[J].癌症,2004,23(9):1052-1055. 被引量:36
  • 2胡苹,娄晋宁,章扬培,马雄君,赵奎明.MGMT在神经胶质瘤中表达的临床意义及联合应用STZ对愈后的影响[J].临床肿瘤学杂志,2006,11(1):19-22. 被引量:10
  • 3郝淑兰(综述),刘丽坤(审校),李宜放(审校).胃癌细胞多药耐药机制及耐药性逆转[J].肿瘤研究与临床,2007,19(1):68-70. 被引量:5
  • 4陈忠平.脑胶质瘤的临床治疗方向[J].中华神经外科杂志,2007,23(2):81-82. 被引量:36
  • 5Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma[J] Am J Pathol, 2007, 170(5): 1445- 1453.
  • 6Louis DN.A molecular genetic model of astrocytoma histopathology [J]. Brain Pathol, 1997,7(2) : 755 - 764.
  • 7Hollstein M,Sidransky D,Vogelstein B,et al. P53 mutations in human cancers [J] . Science, 1991,253(5051): 49 - 53.
  • 8Esteller M, Risques RA, Toyota M, et al. Promoter hypermethylation of the DNA repair gene O^6-methylguanina- DNA-methyhransferase is associated with the presence of G: C to A: T transition mutations in P53 in human colorectal tumorigenesis[J]. Cancer Res, 2001,61 (12) : 4689 - 4692.
  • 9Matsukura S, Miyazaki K, Yakushiji H, et al. Combined loss of expression of O^6-methylguanine-DNA methyl-trasferase and hMLH1 accelerates progression of hepatocellular carcinoma [J] .J Surg Oncol,2003,82(3): 194- 200.
  • 10Reese JS, Mlay E, Gerson SL, et al. Overexpression of human O^6-alkylguanine-DNA alkyltransferase(AGT) prevents MNU induced lymphomas in heterozygous P53 deficient mice [J ]. Oncogene, 2001,20(38) : 5258 - 5263.

引证文献8

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部